Wong, Founder and CEO of HCW Biologics, stated, "In the third quarter 2024, the Company expanded our product portfolio and ...

Q1 2025 Earnings Call Transcript November 13, 2024 Operator: Good morning. Welcome to NETSOL Technologies Fiscal First ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good morning, and welcome to the Lucid Diagnostics Third Quarter ...

General Business and Financial Update Financial ... on Form 10-Q and current reports on Form 8-K, filed with or furnished to the Securities and Exchange Commission and available at www.sec.gov. Any ...

All financial information is reported in U.S. dollars and prepared in accordance with U.S. generally accepted accounting principles ("GAAP”) unless otherwise indicated.

Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value ...

In a statement about his new role, Haytham Yehia said, “It is both a privilege and a personal honor to step into this role, ...

scPharmaceuticals Inc. ( NASDAQ: SCPH) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Nick Colangelo - Investor Relations John Tucker - Chief Executive Officer Steve Parsons - Senior ...

Sanofi is conducting the two-part multicenter, randomized, open-label, controlled, parallel-group study (NCT04643002) to evaluate the safety, efficacy, pharmacokinetics and biomarker data of ...

PMJDY accounts were opened in mission mode during August to December 2014 when PMJDY was launched in 2014. These accounts now ...